Latest Distributions News

Universal Biosensors reported a 28% increase in customer receipts to $1.6 million for Q1 2025, alongside improved cash flow and plans for a new product launch later this year.

MFF Capital Investments Limited has updated its dividend details for the half-year ending December 2024, announcing a fully franked dividend of 8 cents per share and setting reinvestment prices for its DRP and BSP plans.

Cue Energy Resources delivered a robust quarter with production rising to 1,700 boe/d and a $7 million dividend payout, while advancing development projects in Australia and Indonesia.

IRIS Metals has reported a JORC-compliant initial lithium resource at its Beecher Project, alongside high-grade drilling results at Tin Mountain, setting the stage for near-term production and resource expansion in South Dakota.

Axiom Properties reported a $200,000 cash reserve decline to $1.658 million for Q1 2025, driven by strong growth in its PaySure business and a pending $7.6 million land sale from its Mount Barker development.

Harris Technology Group reported steady Q3 FY25 sales of $3.3 million alongside a modest operating cash outflow, while successfully raising $1.5 million to fuel expansion in refurbished electronics.

Ovanti Limited has addressed ASX concerns over its relationship with BNPLPay, clarifying key personnel roles, ownership structures, and cryptocurrency exposure tied to its Licence Agreement.

Desane Group Holdings has secured a seven-year lease extension with Signature Orthopaedics at its Lane Cove property, guaranteeing $5 million in rental income through 2032. This deal reinforces Desane’s strategy to maintain stable medium-term cash flows.

Uscom Limited reported a 14% rise in Q3 customer receipts to $0.73 million, even as cash reserves dropped 38% to $1.34 million, reflecting increased operating costs and global market pressures.

Alexium International Group reported a challenging Q3 FY2025 with lower revenues due to softness in the US bedding market, while making significant technological strides and maintaining a solid funding position.

Nova Eye Medical reported a 27% rise in Q3FY25 sales excluding China, driven by record US performance and a sharp reduction in glaucoma segment losses. The company confirmed FY25 revenue guidance and unveiled plans to expand its iTrack™ technology into ocular drug delivery.

Streamplay Studio Limited reported a remarkable 827% increase in customer receipts for Q3 2025, driven by the full integration of Noodlecake Studios. With a robust cash balance of A$7.7 million and no debt, the company is well-positioned to accelerate growth across cloud gaming, game publishing, and emerging markets.